Bohai Pharmaceuticals Group (BOPH) Stock Price, News & Analysis

Company Overview

Bohai Pharmaceuticals Group, Inc. (OTCMKTS:BOPH) is an investment holding company focused on the research, development, manufacturing and distribution of pharmaceutical and health care products in the People’s Republic of China. Through its operating subsidiaries, the group offers a diversified product portfolio encompassing human pharmaceuticals, feed additives and nutraceuticals. Its business model integrates active pharmaceutical ingredient (API) production, formulation of finished dosage forms and downstream marketing activities to hospitals, retail pharmacies and agricultural supply channels.

In its human health segment, Bohai Pharmaceuticals develops and manufactures prescription and over-the-counter medications, including small-molecule APIs and finished dosage forms such as tablets, capsules and granules. The animal health division supplies essential feed additives, probiotic supplements and antibiotic alternatives to the livestock industry, supporting efforts to enhance animal nutrition and reduce reliance on traditional antibiotics. The company’s nutraceutical offerings further address growing consumer demand for functional health products and dietary supplements.

Established in 2003 and incorporated in the Cayman Islands with headquarters in Hong Kong, Bohai Pharmaceuticals operates manufacturing facilities in Hubei and Liaoning provinces. It has built an extensive distribution network covering major Chinese provinces and has begun exporting selected products to Southeast Asian markets through strategic partnerships. The group’s integrated supply chain and regional production bases aim to ensure consistent product quality and timely delivery to diverse customer segments.

Under the leadership of Chairman and Chief Executive Officer Mr. Jianhua Wang, Bohai Pharmaceuticals has prioritized investment in R&D and strategic collaborations to bolster its product pipeline. The management team leverages decades of industry experience to pursue regulatory approvals, expand manufacturing capacity and explore new therapeutic areas. This combination of operational scale, technical expertise and market reach positions the company to capitalize on growth opportunities in China’s evolving pharmaceutical and agricultural sectors.

Key Stats

• Today's Range: $0.0010 to $0.0010
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0010
• Volume: 50,000 shs
• Average Volume: 30,425 shs
• Market Capitalization: $19.52 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BOPH Stock Analysis - Frequently Asked Questions

How have BOPH shares performed this year?

Bohai Pharmaceuticals Group's stock was trading at $0.0010 at the beginning of the year. Since then, BOPH stock has increased by 0.0% and is now trading at $0.0010.

How do I buy shares of Bohai Pharmaceuticals Group?

Shares of BOPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:BOPH
• CIK: 1443242
• Web: www.bohaipharma.com
• Phone: 86-53-5685-7928
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 19,520,000
• Free Float: N/A
• Market Cap: $19.52 thousand
• Optionable: Not Optionable
• Beta: 1.78